| 6275 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, September 19, 2011 |
null |
| Trop Med Int | 0.773233 |
| tuberculosis testing practices | 0.769333 |
| new HIV infections | 0.77225 |
| Rev Med Virol. | 0.76979 |
| internal transcribed spacer | 0.768009 |
| PLoS One. | 0.785145 |
| World Trade Center | 0.783443 |
| da Silva AJ | 0.770132 |
| CDC Science Clips | 0.896925 |
| Multi-locus variable number | 0.76943 |
| Nutrition Examination Survey | 0.7708 |
| tandem repeat analysis | 0.777448 |
| McClean MD | 0.77019 |
| cardiovascular disease risk | 0.767395 |
| Chief Science Officer | 0.788499 |
| traumatic brain injury | 0.953133 |
| Snawder JE | 0.804542 |
| reproductive technology information | 0.770038 |
| impaired arterial elasticity | 0.779768 |
| rat bartonella strains | 0.774392 |
| blast-related traumatic brain | 0.783897 |
| hormonally active women | 0.767959 |
| normal glucose tolerance | 0.77469 |
| Stephen B. Thacker | 0.853536 |
| bacterial vegetative cells | 0.769642 |
|
| RTS,S/AS01 malaria vaccine | 0.768686 |
| Obstet Gynecol Scand. | 0.76954 |
| Sep | 0.939909 |
| United States | 0.803585 |
| Child Health J. | 0.782116 |
| Occup Environ Med. | 0.77733 |
| dose dependent response | 0.767228 |
| retrospective international study | 0.770045 |
| Public Health Prep. | 0.786463 |
| Jackson Heart Study | 0.789409 |
| person-years analysis program | 0.783872 |
| Olsen LD | 0.793608 |
| public health literature | 0.778192 |
| life table analysis | 0.783908 |
| B. Thacker CDC | 0.885342 |
| AORN Ergonomic Tool | 0.766473 |
| respiratory syndrome coronavirus | 0.768193 |
| Tuberc Lung Dis. | 0.775702 |
| Clin Vaccine Immunol. | 0.778035 |
| Osborn LV | 0.768711 |
| et al | 0.787142 |
| severe traumatic brain | 0.782489 |
| New England states | 0.779605 |
| Kriech AJ | 0.768036 |
|
CLICK HERE |
| 6606 |
Centers for Disease Control and Prevention |
Html |
en |
A decade of sustaining best practices for tobacco control: Indiana's story. |
The Indiana Tobacco Prevention and Cessation Agency (ITPC) was created in 2000 to address high tobacco use rates. This independent state agency, using Centers for Disease Control and Prevention (CDC) Best Practices for Comprehensive Tobacco Control Programs, administered a comprehensive program that supported community health coalitions and evidence-based public policy changes. |
| tobacco use cessation | 0.417991 |
| tobacco control advocates | 0.446242 |
| tobacco consumption | 0.40862 |
| community-based tobacco control | 0.445758 |
| high tobacco | 0.429908 |
| capita public health | 0.386645 |
| tobacco control program | 0.559259 |
| tobacco control programs | 0.795474 |
| tobacco users | 0.404605 |
| itpc executive board | 0.516485 |
| tobacco use–related diseases | 0.438231 |
| comprehensive tobacco control | 0.512445 |
| Indiana State Department | 0.464447 |
| smoke-free air policies | 0.391684 |
| comprehensive state tobacco | 0.451199 |
| current statewide tobacco | 0.418114 |
| tobacco industry | 0.4943 |
| indiana tobacco | 0.561054 |
| health care | 0.400303 |
| Best Practices | 0.503298 |
| tobacco control partners | 0.473359 |
| evidence-based tobacco control | 0.427858 |
| Public health | 0.462087 |
| independent state agency | 0.397085 |
| public education campaigns | 0.380773 |
|
| Indiana Tobacco Prevention | 0.532096 |
| smoke-free air ordinances | 0.379144 |
| Indiana Tobacco Quitline | 0.52302 |
| tobacco prevention funding | 0.442748 |
| Indiana legislature | 0.394563 |
| high tobacco prices | 0.410944 |
| Public health leaders | 0.385056 |
| smoke-free workplace law | 0.409696 |
| tobacco taxes | 0.399158 |
| independent tobacco control | 0.449907 |
| state tobacco control | 0.530302 |
| tobacco use rates | 0.422638 |
| Tobacco Master Settlement | 0.426863 |
| tobacco companies | 0.452667 |
| statewide smoke-free air | 0.393301 |
| Indiana State Senator | 0.396919 |
| smoke-free air | 0.432175 |
| tobacco control interventions | 0.472938 |
| new Tobacco Prevention | 0.448867 |
| Indiana Youth Tobacco | 0.45906 |
| tobacco use objectives | 0.393153 |
| tobacco control | 0.961404 |
| tobacco use prevention | 0.445487 |
| tobacco products increase | 0.412777 |
|
CLICK HERE |
| 9820 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Vital Signs - Binge Drinking: A Dangerous Problem among Women and Girls infographic |
CDC Vital Signs - Binge Drinking Female |
| Factor Surveillance | 0.526366 |
| Youth Risk Behavior | 0.764996 |
|
| American Indian/Alaskan Native | 0.84447 |
| different file formats | 0.808113 |
|
CLICK HERE |
| 9916 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Total Worker Health : Goals |
The TWH™ Program includes an intramural component and an extramural component, comprised of four Centers of Excellence to Promote a Healthier Workforce. Both of these components conduct research on the integration of health protection and health promotion; communication of current knowledge, successful approaches, and challenges, and advocacy of the concepts and practices of total worker health to our partners and stakeholders. |
| Healthier Workforce | 0.383526 |
| employee groups | 0.379774 |
| Total Worker Health® | 0.978478 |
| NIOSH grants | 0.405805 |
| specific programs | 0.409503 |
| research | 0.395443 |
| NIOSH-funded Total Worker | 0.482291 |
| strategic plan | 0.39696 |
| NIOSH Total Worker | 0.738347 |
| public sector work | 0.452348 |
| health protection/health promotion | 0.476506 |
| joint effects | 0.432498 |
| NORA Sector Programs | 0.479296 |
| government agencies | 0.378913 |
| matrix-like fashion | 0.384052 |
| overall health | 0.455702 |
| multiple programs | 0.399918 |
| extramural research | 0.383211 |
| statutory programs | 0.402459 |
| global efforts | 0.385677 |
| professional associations | 0.378971 |
| Injury Cross-Sector Program | 0.480233 |
| Federal sector | 0.382411 |
| effective practices | 0.380404 |
| workplace health protection | 0.471805 |
|
| non-work factors | 0.44319 |
| strategic goals | 0.423728 |
| partnership efforts | 0.388329 |
| Strategic Goal | 0.531844 |
| overall safety | 0.430525 |
| occupational illness | 0.446735 |
| service efforts | 0.391295 |
| adverse health outcomes | 0.482314 |
| Total Worker Healthâ„¢ | 0.478776 |
| worker illness | 0.405837 |
| cross-cutting issues | 0.387222 |
| Health® Centers | 0.381863 |
| force health | 0.406159 |
| industrial sectors | 0.381749 |
| health promotion programs | 0.648865 |
| Research products | 0.380377 |
| Cross-Sector Programs | 0.491459 |
| Construction Sector | 0.386732 |
| high priority | 0.383695 |
| intermediate goal | 0.642331 |
| health protection | 0.740889 |
| current funding opportunities | 0.427878 |
| worker health® program | 0.880724 |
| integrated health protection | 0.578523 |
|
CLICK HERE |
| 11322 |
Centers for Disease Control and Prevention |
Html |
null |
Evidence Reviews and Research Summaries |
This page provides tools and resources for researching and evaluating health literacy practice. |
|
|
CLICK HERE |
| 11888 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance for Healthcare Workers Providing Care in West African Countries Affected by the Ebola Outbreak: Limiting Heat Burden While Wearing Personal Protective Equipment (PPE) |
null |
| Personal protective equipment | 0.22203 |
| hot environment | 0.269952 |
| proper rest breaks | 0.271785 |
| previous work experience | 0.245387 |
| body weight | 0.256751 |
| heat illness | 0.255235 |
| heat stress | 0.311856 |
| heat-related illnesses | 0.759044 |
| Heat Safety Tool | 0.253519 |
| electrolyte replacement fluids | 0.694319 |
| heat stroke | 0.261538 |
| risk factors | 0.220846 |
| heat index table | 0.25347 |
| usual work shift | 0.338255 |
| Schedule workers | 0.243713 |
| heat-related illness | 0.847412 |
| rest breaks | 0.374938 |
| body weight changes | 0.224173 |
| heat index | 0.314454 |
| Limited electrical power | 0.223526 |
| shorter work shifts | 0.332358 |
| previous heat-related illness | 0.387582 |
| core body temperature | 0.323583 |
| frequent rest breaks | 0.252742 |
| work shift | 0.364474 |
|
| rest area | 0.396485 |
| NIOSH Heat Stress | 0.24816 |
| PPE healthcare workers | 0.448545 |
| Heat stress control | 0.235461 |
| Occupational Safety | 0.255085 |
| work exposure time | 0.253856 |
| hot environmental conditions | 0.231555 |
| heat-related morbidity | 0.281353 |
| potentially unacclimatized workers | 0.270927 |
| pre-existing medical conditions | 0.225947 |
| shaded area | 0.220822 |
| limited air movement | 0.224344 |
| treatment areas—waterproof apron | 0.22147 |
| indoor heat sources | 0.255444 |
| oral rehydration salts | 0.418941 |
| heat casualty management | 0.235968 |
| heat-related symptoms | 0.294572 |
| Help healthcare workers | 0.329965 |
| body temperature increase | 0.223928 |
| healthcare workers | 0.969556 |
| heat index increases | 0.252091 |
| West Africa | 0.225425 |
| risk | 0.223615 |
| hot working conditions | 0.239019 |
|
CLICK HERE |
| 12170 |
Centers for Disease Control and Prevention |
Html |
en |
Meningitis | Lab Manual | Id and Characterization of Hib | CDC |
Primary Culture and Presumptive Identification Laboratory Methods. |
| H. influenzae serotypes | 0.597527 |
| saline | 0.568695 |
| filter paper | 0.584946 |
| monovalent antisera | 0.576755 |
| growth requirements | 0.601453 |
| NAD growth factor | 0.61098 |
| ID Quad plate | 0.564777 |
| horse blood | 0.663285 |
| paper disks | 0.569099 |
| chocolate agar plate | 0.555152 |
| Quad plate | 0.583516 |
| chocolate agar | 0.572415 |
| rabbit blood agar | 0.571874 |
| oxidase reagent | 0.612697 |
| Haemophilus ID Quad | 0.655964 |
| Haemophilus spp | 0.599378 |
| growth factor requirement | 0.64844 |
| CAP | 0.575473 |
| cell suspension | 0.700402 |
| blood agar | 0.582938 |
| H. influenzae | 0.97581 |
| H. influenzae strain | 0.597653 |
| H. influenzae serotype | 0.602531 |
| oxidase test | 0.576131 |
|
| heart infusion agar | 0.568868 |
| plate | 0.596855 |
| antisera | 0.63817 |
| H. influenzae isolate | 0.619606 |
| factor requirement test | 0.587637 |
| Haemophilus influenzae | 0.588567 |
| serotype-specific antisera | 0.610467 |
| polyvalent antiserum | 0.605164 |
| µl inoculation loops | 0.562149 |
| H. influenzae growth | 0.631436 |
| NAD growth requirements | 0.561447 |
| Hib vaccination program | 0.55289 |
| different serogroup-specific antisera | 0.560171 |
| hemin | 0.593596 |
| ID Quad plates | 0.579366 |
| overnight growth | 0.55594 |
| costly antisera | 0.557706 |
| horse blood cells | 0.554892 |
| Individual serotype-specific antisera | 0.564216 |
| Figure | 0.558738 |
| NAD | 0.621415 |
| medium containing NAD | 0.554911 |
| H. haemolyticus | 0.672064 |
| growth | 0.663153 |
|
CLICK HERE |
| 12262 |
Centers for Disease Control and Prevention |
Html |
en |
Alcohol Poisoning Deaths |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 14117 |
Centers for Disease Control and Prevention |
Html |
en |
HIV Testing and Service Delivery Among Black Females - 61Health Department Jurisdictions, United States, 2012-2014 |MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| HIV testing events | 0.315599 |
| National HIV/AIDS Strategy | 0.267799 |
| CDC-funded HIV testing | 0.267699 |
| new HIV infections | 0.262652 |
| HIV testing event | 0.219736 |
| United States | 0.22978 |
| HIV testing services | 0.270059 |
| widespread HIV testing | 0.237405 |
| Evaluation HIV testing | 0.220162 |
| HIV positivity rate | 0.303243 |
| HIV positivity rates | 0.225337 |
| HIV infections | 0.390291 |
| HIV testing events†| 0.235588 |
| HIV infection status | 0.217197 |
| HIV testing efforts | 0.220431 |
| hiv prevention program | 0.374372 |
| new HIV | 0.275991 |
| HIV diagnoses | 0.217204 |
| HIV positivity | 0.307596 |
|
| HIV testing programs | 0.22581 |
| health departments | 0.253221 |
| newly diagnosed HIV | 0.721728 |
| local health departments | 0.232578 |
| HIV transmission | 0.217578 |
| NHM&E HIV testing | 0.233784 |
| testing events | 0.346074 |
| HIV prevention services | 0.245149 |
| partner services | 0.273755 |
| HIV medical care | 0.910229 |
| black females | 0.582578 |
| HIV testing activities | 0.235245 |
| HIV surveillance data | 0.231399 |
| Prevention Program Monitoring | 0.238854 |
| HIV testing data | 0.258483 |
| National HIV Prevention | 0.330619 |
| HIV testing | 0.48524 |
| current HIV status | 0.214852 |
| HIV test date | 0.21277 |
|
CLICK HERE |
| 15581 |
Centers for Disease Control and Prevention |
Html |
en |
Increased Hepatitis C Virus HCV Detection in Women ofChildbearing Age and Potential Risk for Vertical Transmission -United States and Kentucky, 2011-2014 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| perinatal HCV case | 0.350405 |
| antibody-positive pregnant women | 0.213821 |
| HCV testing rates | 0.305672 |
| HCV-infected women | 0.440421 |
| HCV infection | 0.92194 |
| injection drug | 0.222791 |
| United States | 0.207293 |
| birth certificate data | 0.383311 |
| HCV surveillance | 0.364005 |
| annual HCV | 0.334391 |
| HCV prevalence | 0.282296 |
| HCV incidence | 0.293435 |
| perinatal HCV infection | 0.333573 |
| HCV testing | 0.739232 |
| pregnant women | 0.559036 |
| children | 0.235277 |
| maternal hcv infection | 0.388683 |
| acute HCV surveillance | 0.319844 |
| HCV risk | 0.293298 |
| infant HCV antibody | 0.329395 |
| HCV detection rate | 0.378427 |
| newly diagnosed HCV | 0.325 |
| public health | 0.296492 |
|
| HCV screening | 0.287183 |
| HCV infection status | 0.432531 |
| HCV detection | 0.704356 |
| HCV viral loads | 0.331883 |
| infants | 0.320293 |
| HCV testing rate | 0.32655 |
| HCV surveillance data | 0.333684 |
| HCV laboratory-based surveillance | 0.308563 |
| HCV detection rates | 0.350499 |
| positive HCV antibody | 0.304354 |
| HCV infection account | 0.354347 |
| HCV-infected mothers | 0.284521 |
| current HCV infection | 0.35215 |
| maternal HCV diagnosis | 0.322544 |
| annual HCV detection | 0.324883 |
| commercial laboratory data | 0.236589 |
| acute HCV infection | 0.425192 |
| HCV case identification | 0.33163 |
| HCV | 0.960367 |
| HCV antibody | 0.386653 |
| laboratory data | 0.260572 |
| HCV case | 0.380553 |
| routine HCV testing | 0.372408 |
|
CLICK HERE |